Sevoflurane in Electroconvulsive Therapy

Phase 4CompletedNCT01905904

Inonu University25 enrolled

Overview

The purpose of the study was to investigate the effects of different doses of sevoflurane used in electroconvulsive therapy (ECT) on duration of seizure, hemodynamic response and recovery profiles

Motor (EMG) and electroencephalography seizure duration (EEG), heart rate (HR) and mean arterial pressure (MAP) values, and recovery times were recorded.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

TRIPLE

Enrollment

Conditions

ECT Anesthesia

Interventions

sevoraneDRUG

Sevorane 4% Sevorane 7%

Eligibility

Sex: ALLMin age: 18 YearsMax age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Study included 25 patients of American Society of Anesthesiologists (ASA) physical status I-II aged between 18-60 years who were scheduled for ECT sessions under general anesthesia Exclusion Criteria: * Pregnancy * Cerebrovascular disease * Epilepsy * Unstable cardiovascular disease * Chronic obstructive pulmonary disease; and * Renal or hepatic failure

Locations (1)

Inonu Unıversity School of Medicine

Malatya, Turkey (Türkiye)

Outcomes

Primary Outcomes

sevoflurane used in electroconvulsive therapy (ECT) on duration of seizure

Time frame: taken prior to the seizure

Secondary Outcomes

sevoflurane used in electroconvulsive therapy (ECT) on hemodynamic response.

Time frame: taken prior to the seizure

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.